News Letters 2015


Would you like to submit an article for inclusion in IMPACT? Click here for guidance notes.

Issue
Number

Date Topics

 

IMPACT
Volume  9
Link opens in new window007 
PDF 131KB

 

December 2015

 

Local newsletter providing information of the variation in antibiotic prescribing and the increasing cost-effective use of quetiapine by switching from quetiapine modified release (XL) to immediate release (IR)

 

IMPACT
Volume  9
Link opens in new window006 
PDF 131KB    
 

 

November 2015

 

Local newsletter providing a reminder on the provision of information to women on the risks associated with valproate related medicines, the risks from new insulin preparations and nortriptyline for neuropathic pain.  Also in this issue information on self-monitoring blood-glucose for diabetes and Levosert - the new levonorgestrel intrauterine delivery system

IMPACT
Volume 9      
    Link opens in new window 005    
 PDF 80KB

 

September 2015

 

Local newsletter providing information on the increasing use of drugs for erectile dysfunction and the generic prescribing of eye drops

IMPACT
Volume       9    
   Link opens in new window004    
 PDF 86KB

 

August 2015

 

Local newsletter providing information on Temazepam prescribing change June 2015, the Vale of Leven Public Enquiry into C difficile, an audit of adult Gentamicin prescribing, administration and monitoring (PAM) charts in ARI and the discontinuation of Lumigan 0.3% multidose eye drops

IMPACT
Volume 9  
  Link opens in new window 003  
 PDF 133KB

 

July 2015

 

Local newsletter providing information on the Management of Osteoporosis and the Prevention of Fragility Fractures - SIGN 142

IMPACT
Volume 9
Link opens in new window002 
 PDF 106KB

 

May 2015

Local newsletter providing information on Don't Waste A Breath Unused Inhaler Campaign, the approval of fidaxomicin tablets (Dificlir)  for use in NHS Grampian on the advice of a Medical Microbiologist or Infection Specialists, the prescribing of generic sildenafil and Mycophenolate mofetil (CellCept) and mycophenolic acid: risk of hypogammaglobulinaemia and risk of bronchiectasis

IMPACT
Volume 9
Link opens in new window001 PDF 91KB
January 2015 Local newsletter providing information on Antiplatelets post cardiac surgery, an empirical antibiotic guideline update for the Acute sector, the availability of generic pregabalin, the formulary reclassification of renavit and a question from the Medicines Information Database on non-steroidal anti-inflammatory drug (NSAID)

END